You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IC

Showing 1 - 25 of 3,446
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IC-MPGN Trial (Placebo, iptacopan)

Not yet recruiting
  • IC-MPGN
  • (no location specified)
Feb 23, 2023

Heart Failure Trial (MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS, CONTROL)

Not yet recruiting
  • Heart Failure
  • MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS
  • CONTROL
  • (no location specified)
Jun 19, 2023

Interstitial Cystitis, Bladder Pain Syndrome, Urologic Diseases Trial in Winston-Salem (Auricular Acupressure)

Not yet recruiting
  • Interstitial Cystitis
  • +3 more
  • Auricular Acupressure
  • Winston-Salem, North Carolina
    Atrium Health Wake Forest Baptist Health
May 3, 2023

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023

Cataract, Presbyopia, Irregular; Contour of Cornea Trial in Singapore

Active, not recruiting
  • Cataract
  • +2 more
    • Singapore, Singapore
      Singapore Eye Research Institute / Singapore National Eye Centre
    Jan 11, 2023

    Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)

    Recruiting
    • Efficacy
    • +2 more
    • Hepenofovir Fumarate Tablets
    • Jilin, Changchun, China
      The First Hospital of Jilin University
    Nov 2, 2023

    IC - Interstitial Cystitis Trial in Pittsburgh (Ferumoxytol, Gadobutrol)

    Recruiting
    • IC - Interstitial Cystitis
    • Pittsburgh, Pennsylvania
      UPMC Magee Women's Hospital
    Apr 10, 2023

    Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer Trial (GERONTE)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • GERONTE
    • (no location specified)
    Jan 31, 2023

    Research Into Factors Determining Participation in 2

    Not yet recruiting
    • Heart Failure
    • PRADO-IC
    • Remote monitoring
    • (no location specified)
    Dec 12, 2022

    Intermittent Claudication, Peripheral Artery Disease Trial (GFH312, Placebo)

    Not yet recruiting
    • Intermittent Claudication
    • Peripheral Artery Disease
    • (no location specified)
    Nov 9, 2022

    Cataract, Presbyopia, Irregular Astigmatism Trial in Makati City, Singapore (IC-8 Intraocular Lens (IOL))

    Recruiting
    • Cataract
    • +2 more
    • IC-8 Intraocular Lens (IOL)
    • Makati City, Philippines
    • +1 more
    Dec 6, 2022

    HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

    Recruiting
    • HIV
    • +5 more
    • Pfizer Bivalent COVID-19 Vaccine
    • Moderna Bivalent mRNA vaccine
    • Melbourne, Victoria, Australia
      Alfred Health
    Jan 31, 2023

    Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS) Trial (Clarix Flo, Placebo)

    Not yet recruiting
    • Interstitial Cystitis
    • Painful Bladder Syndrome (PBS)
    • Clarix Flo
    • Placebo
    • (no location specified)
    Oct 23, 2023

    Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS) Trial (Clarix Flo, Placebo)

    Not yet recruiting
    • Interstitial Cystitis
    • +2 more
    • Clarix Flo
    • Placebo
    • (no location specified)
    Oct 17, 2023

    IC-8 Apthera IOL New Enrollment Post Approval Study

    Recruiting
    • Cataract
    • +2 more
      • Dothan, Alabama
      • +10 more
      Sep 23, 2023

      C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

      Not yet recruiting
      • C3G
      • +11 more
      • (no location specified)
      Apr 13, 2023

      Rotator Cuff Tears Trial in New York (Indocyanine Green)

      Recruiting
      • Rotator Cuff Tears
      • Indocyanine Green
      • New York, New York
        NYU Langone Health
      Oct 14, 2022

      Radiation Exposure Trial in New York (Rampart IC, M1128, Lead Apron and Ancillary Shield, Rampart IC, M1128 and Lead Apron)

      Enrolling by invitation
      • Radiation Exposure
      • Rampart IC, M1128
      • +2 more
      • New York, New York
        Lenox Hill Hospital
      Jul 21, 2022

      Carotid Occlusion Trial in Miami, Chicago, Burlington (EC-IC bypass)

      Withdrawn
      • Carotid Occlusion
      • EC-IC bypass
      • Miami, Florida
      • +2 more
      Feb 16, 2022

      Long-Term Clinical Acceptability and Satisfaction With IC-8

      Completed
      • Cataract
      • Presbyopia
      • IC-8 IOL
      • Ahaus, Germany
      • +6 more
      May 12, 2022

      Decoding Risks and Rewards in Ischemic Stroke Surgery

      Completed
      • Ischemic Stroke
        • Taichung, Taiwan
          China Medical University Hospital
        Oct 18, 2023

        Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

        Active, not recruiting
        • Neuroblastoma
        • iC9-GD2 T Cells - frozen
        • +5 more
        • Houston, Texas
        • +1 more
        Jan 4, 2023

        Accuracy Evaluation of the IdentiClone Dx IGH Assay

        Not yet recruiting
        • B-Cell Lymphoproliferative Disorder
        • IdentiClone Dx IGH (IC IGH Dx) Assay
        • San Diego, California
        • +2 more
        Oct 30, 2023

        Intraocular Pressure Trial (iCare ST500, GAT, iCare IC200)

        Not yet recruiting
        • Intraocular Pressure
        • iCare ST500
        • +2 more
        • (no location specified)
        Feb 14, 2023

        Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

        Recruiting
        • Recurrent B-Cell Non-Hodgkin Lymphoma
        • +7 more
        • Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
        • +2 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jul 14, 2022